Critical illness myopathy and polyneuropathy
- 118 Downloads
Neuromuscular weakness commonly develops in the setting of critical illness. This weakness delays recovery and often causes prolonged ventilator dependence. An axonal sensory-motor polyneuropathy, critical illness polyneuropathy (CIP), is seen in up to one third of critically ill patients with the systemic inflammatory response syndrome (usually due to sepsis). An acute myopathy, critical illness myopathy (CIM), frequently develops in a similar setting, often in association with the use of corticosteroids and/or nondepolarizing neuromuscular blocking agents. These patients are often difficult to evaluate due to the limitations imposed by the critical care setting and may be further complicated by the presence of both CIP and CIM in varying degrees. This paper reviews the clinical and electrophysiologic features of these disorders, as well as the putative pathophysiology. In the case of CIM, an animal model has provided evidence that weakness in this disorder is caused by muscle membrane inexcitability due to altered membrane sodium currents and loss of myosin thick filaments.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 3.Trojaborg W, Weimer LH, Hayes AP: Electrophysiologic studies in critical illness associated weakness: myopathy or neuropathy —a reappraisal. Clin Neurophysiol 2001, 112:1586–1593. A detailed electrophysiologic study in patients with critical illness myopathy utilizing direct muscle stimulation, quantitative electromyography, and motor unit estimation.PubMedCrossRefGoogle Scholar
- 14.Bird SJ: Critical care: myopathies and disorders of neuromuscular transmission. In Neuromuscular Function and Disease. Edited by Brown WF, Bolton CF, Aminoff MJ. Philadelphia: Harcourt-Brace; 2002:1507–1520.Google Scholar
- 16.Ashcroft FM: Ion Channels and Disease. London: Academic Press; 2000.Google Scholar
- 20.Rich MM, Pinter MJ: Sodium channel inactivation in an animal model of acute quadriplegic myopathy. Ann Neurol 2001, 50:26–33. A patch clamp analysis of sodium current in an animal model of critical illness myopathy demonstrating that an altered voltage dependence of sodium channel inactivation may underlie electrical inexcitability of muscle in this syndrome.PubMedCrossRefGoogle Scholar
- 26.Larsson L, Li X, Edstrom LI, et al.: Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels. Crit Care Med 2000, 28:34–45. A study examining protein and mRNA levels of muscle structural proteins in muscle biopsies from patients with critical illness myopathy.PubMedCrossRefGoogle Scholar
- 28.Rich MM, McGarvey ML: ECG changes during septic shock. Cardiology 2002, in press.Google Scholar
- 34.Berek K, Margreiter J, Willeit J: Polyneuropathies in critically ill patients: a prospective evaluation. Intensive Care Med 1993, 22:849–855.Google Scholar
- 36.DeLetter MC, Schmitz PI, Visser LH, et al.: Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 2001, 29:2281–2286. This study prospectively evaluated risk factors for the development of critical illness polyneuropathy or critical illness myopathy. They found that a high-risk group could be identified by the presence of systemic inflammatory response syndrome and more severe critical illness, as measured by the Acute Physiology and Chronic Health Evaluation (APACHE)-III score.CrossRefGoogle Scholar
- 39.Teener JW, Rich MM, Bird SJ: Other causes of acute weakness in the intensive care unit.In Critical Care Neurology. Edited by Miller DH, Raps EC. Boston: Butterworth-Heinemann; 1999:69–89.Google Scholar
- 41.Zochodne DW, Bolton CF, Gilbert JJ: Polyneuropathy in critical illness: pathologic features. Ann Neurol 1985, 18:160–166.Google Scholar
- 42.Druschky A, Herkert M, Radespiel-Troger M, et al.: Critical illness polyneuropathy: clinical findings and cell culture assay of neurotoxicity assessed by a prospective study. Intensive Care Med 2001, 27:686–693. A cell culture assay of neurotoxicity may suggest that a low-molecular weight toxin may play a role in the pathogenesis of critical illness polyneuropathy.PubMedCrossRefGoogle Scholar